RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Murali Yallapu to Drug Delivery Systems

This is a "connection" page, showing publications Murali Yallapu has written about Drug Delivery Systems.
Connection Strength

2.282
  1. Yallapu MM, Nagesh PK, Jaggi M, Chauhan SC. Therapeutic Applications of Curcumin Nanoformulations. AAPS J. 2015 Nov; 17(6):1341-56.
    View in: PubMed
    Score: 0.397
  2. Yallapu MM, Jaggi M, Chauhan SC. Design and engineering of nanogels for cancer treatment. Drug Discov Today. 2011 May; 16(9-10):457-63.
    View in: PubMed
    Score: 0.291
  3. Yallapu MM, Foy SP, Jain TK, Labhasetwar V. PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications. Pharm Res. 2010 Nov; 27(11):2283-95.
    View in: PubMed
    Score: 0.281
  4. Tiwari R, Kolli M, Chauhan S, Yallapu MM. Tabletized Nanomedicine: From the Current Scenario to Developing Future Medicine. ACS Nano. 2024 05 07; 18(18):11503-11524.
    View in: PubMed
    Score: 0.180
  5. Ghali ENHK, Chauhan SC, Yallapu MM. Inulin-based formulations as an emerging therapeutic strategy for cancer: A comprehensive review. Int J Biol Macromol. 2024 Feb; 259(Pt 1):129216.
    View in: PubMed
    Score: 0.177
  6. Laskar P, Jaggi M, Chauhan SC, Yallapu MM. Biomolecule-functionalized nanoformulations for prostate cancer theranostics. J Adv Res. 2023 09; 51:197-217.
    View in: PubMed
    Score: 0.163
  7. Massey AE, Malik S, Sikander M, Doxtater KA, Tripathi MK, Khan S, Yallapu MM, Jaggi M, Chauhan SC, Hafeez BB. Clinical Implications of Exosomes: Targeted Drug Delivery for Cancer Treatment. Int J Mol Sci. 2021 May 17; 22(10).
    View in: PubMed
    Score: 0.147
  8. Chowdhury P, Roberts AM, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM. Magnetic nanoformulations for prostate cancer. Drug Discov Today. 2017 08; 22(8):1233-1241.
    View in: PubMed
    Score: 0.112
  9. Yallapu MM, Chauhan N, Othman SF, Khalilzad-Sharghi V, Ebeling MC, Khan S, Jaggi M, Chauhan SC. Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles. Biomaterials. 2015 Apr; 46:1-12.
    View in: PubMed
    Score: 0.095
  10. Yallapu MM, Ebeling MC, Khan S, Sundram V, Chauhan N, Gupta BK, Puumala SE, Jaggi M, Chauhan SC. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Mol Cancer Ther. 2013 Aug; 12(8):1471-80.
    View in: PubMed
    Score: 0.085
  11. Yallapu MM, Othman SF, Curtis ET, Bauer NA, Chauhan N, Kumar D, Jaggi M, Chauhan SC. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomedicine. 2012; 7:1761-79.
    View in: PubMed
    Score: 0.078
  12. Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today. 2012 Jan; 17(1-2):71-80.
    View in: PubMed
    Score: 0.075
  13. Yallapu MM, Jaggi M, Chauhan SC. Poly(?-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells. Macromol Biosci. 2010 Oct 08; 10(10):1141-51.
    View in: PubMed
    Score: 0.071
  14. Yallapu MM, Jaggi M, Chauhan SC. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces. 2010 Aug 01; 79(1):113-25.
    View in: PubMed
    Score: 0.068
  15. Gong Y, Zhi K, Nagesh PKB, Sinha N, Chowdhury P, Chen H, Gorantla S, Yallapu MM, Kumar S. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia. Viruses. 2020 05 20; 12(5).
    View in: PubMed
    Score: 0.034
  16. Ganju A, Khan S, Hafeez BB, Behrman SW, Yallapu MM, Chauhan SC, Jaggi M. miRNA nanotherapeutics for cancer. Drug Discov Today. 2017 02; 22(2):424-432.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support